Edition:
United Kingdom

Conatus Pharmaceuticals Inc (CNAT.OQ)

CNAT.OQ on NASDAQ Stock Exchange Global Market

0.77USD
14 Jun 2019
Change (% chg)

-- (--)
Prev Close
$0.77
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
147,434
52-wk High
$6.73
52-wk Low
$0.69

Select another date:

Tue, Feb 12 2019

BRIEF-Conatus Completes Enrollment In Phase 2B Clinical Trial Of Emricasan In Patients With Decompensated Nash Cirrhosis

* CONATUS ANNOUNCES COMPLETION OF ENROLLMENT IN ENCORE-LF PHASE 2B CLINICAL TRIAL OF EMRICASAN IN PATIENTS WITH DECOMPENSATED NASH CIRRHOSIS

Select another date: